Joanne Ostman
Medical · Burnsville, MNNPI 1891724696
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $281 and has fallen 91.9% since, to $23 in 2025.
Across 42 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$112
- Incyte Corporation$103
- Sanofi$98
- Regeneron Healthcare Solutions, Inc.$93
- Lilly USA, LLC$66
- VYNE Pharmaceuticals Inc.$59
- plus $227 from 9 others
What the payments were for
- Food & beverage$74498%
- Education$152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 7 | $112 |
| Incyte Corporation | 6 | $103 |
| Sanofi | 6 | $98 |
| Regeneron Healthcare Solutions, Inc. | 5 | $93 |
| Lilly USA, LLC | 5 | $66 |
| VYNE Pharmaceuticals Inc. | 2 | $59 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $58 |
| LEO Pharma Inc. | 2 | $34 |
| Amgen | 2 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| UCB, Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Pfizer | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$759 in reported general payments places this provider in the 75th percentile of 202 medical providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 30 | $1,442 |
| Ketoconazole | 57 | $1,114 |
| Metronidazole | 21 | $930 |
| Clobetasol Propionate | 24 | $732 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 16 | $233 |
| Triamcinolone Acetonide | 33 | $222 |
| Hydrocortisone | 17 | $112 |
Paid to pharmacies, not to this prescriber.
Other medical in Burnsville
- Kristina ThissenRogers$178K
- Cynthia KonrathMinnetonka$95K
- Tyler JohnsonWaconia$28K
- Eliza AbrahamWhite Bear Lake$19K
- Tobie MeyerMaple Grove$13K
- Emily BurkmanWhite Bear Lake$6K
- Sarah SeilerMaple Grove$4K
- Kerry GuntliEden Prairie$3K
- Katie PetersonMaple Grove$3K
- Kathryn JelleSaint Louis Park$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.